Jun 13 2017
Nemaura Medical Inc., a medical device company announced the latest version of the sensor component of it’s sugarBEAT® non-invasive wireless skin-patch has achieved a more than 300% improvement in glucose detection.
This major improvement is expected to enhance sugarBEAT® accuracy as expressed through MARD, by enabling diabetics to better detect small fluctuations in glucose levels, and for sugarBEAT® to detect glucose at very low levels.
The sugarBEAT® clinical trial program, involving up to 75 patients over 525 days, is due to commence shortly, with product launch anticipated before the end of 2017 in the UK.
The needle-free and daily-disposable format of the sugarBEAT® skin-patch is expected to provide a non-invasive and flexible way for diabetics to better manage their glucose levels.
SugarBEAT’s® cost-effective design, consisting of a reusable Bluetooth-enabled body-worn transmitter containing a low-cost disposable adhesive skin-patch will make glucose monitoring more affordable, especially for non-insulin-injecting diabetics.
Alongside the sugarBEAT® wireless skin-patch, Nemaura has also successfully developed and tested the associated sugarBEAT® mobile phone application.
This Medical-grade App connects by Bluetooth to the skin-patch and displays glucose readings on a continuous basis as well as providing summary Ambulatory Glucose Profile (AGP) trends.
The App also allows for additional manual lifestyle inputs helping diabetics to better understand and manage their condition.
Source: http://www.nemauramedical.com/